Medx Health

Medx Health EBITDA per Share

The EBITDA per Share of Medx Health (MDX.V) as of Nov 17, 2026 is -0.02 CAD. In the previous year, EBITDA per Share was -0.01 CAD — a change of 99.39% (lower).

EBITDA per Share

-0.02CAD

YoY

99.39%

Last updated:

EBITDA per Share of Medx Health is 2025 -0.02 CAD. EBITDA per Share of Medx Health was 2024 -0.01 CAD. It decreases by 99.39% lower compared to the previous year.

The Medx Health EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-0.03 CAD
Jan 1, 2019
-0.02 CAD
Jan 1, 2020
-0.02 CAD
Jan 1, 2021
-0.02 CAD
Jan 1, 2022
-0.02 CAD
Jan 1, 2023
-0.01 CAD
Jan 1, 2024
-0.01 CAD
Jan 1, 2025
-0.02 CAD
The Medx Health EBITDA per Share history
YEAREBITDA per ShareYoY
-0.02CAD+99.39%
-0.01CAD-5.01%
-0.01CAD-56.18%
-0.02CAD-16.04%
-0.02CAD+47.78%
-0.02CAD-19.55%
-0.02CAD-29.15%
-0.03CAD+135.50%
-0.01CAD+8.36%
-0.01CAD+370.31%
-0.00CAD+24.91%
-0.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medx Health Stock analysis

What does Medx Health do? MedX Health Corp develops and sells medical devices and software focused on skin health. Its core products include SIAscopy technology for scanning skin moles and lesions, integrated with the DermSecure telemedicine platform. The company manufactures hand-held devices like SIAMETRICS, SIMSYS, and MoleMate, which use light-based technology to detect skin issues up to two millimeters beneath the surface without pain or invasion. These devices are used in dermatology clinics and rehabilitation centers for early skin cancer detection and non-invasive treatment of pain and tissue damage. The company's telemedicine platform, SIAscopy on DermSecure, enables remote operation of its scanning technology through web-based services. Phototherapy devices utilizing lower-level laser and LED light energy are sold to healthcare providers for pain relief and tissue repair in rehabilitation settings. The primary customers are dermatologists, clinics specializing in skin health, and rehabilitation facilities seeking non-invasive diagnostic and treatment solutions. MedX Health Corp generates revenue through direct sales of its medical devices, telemedicine software, and phototherapy equipment. The SIAscopy technology and associated products are marketed to healthcare professionals in the dermatology and rehabilitation sectors. The company's focus on skin screening and pain-free tissue repair drives sales of its hand-held devices and telemedicine platform to medical institutions requiring advanced diagnostic tools. Medx Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medx Health stock

EBITDA per Share of Medx Health is -0.02 CAD in 2025.

EBITDA per Share of Medx Health changed from -0.01 CAD to -0.02 CAD, representing a 99.39% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Medx Health since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Medx Health

All Key Metrics — Medx Health